Beckman Coulter has commercially launched its DxH 900 hematology analyzer. The new instrument is aimed at mid- to high-volume clinical labs performing complete blood count and white blood cell differential tests. The firm said the DxH 900 offers high-resolution analysis of cells in their near-native states, providing a precise cellular assessment for red blood cell, platelet, and white blood cell test results on the first pass.
The DxH 900 is now available for sale in Europe, the US, Canada, Australia, and New Zealand.
Beckman Coulter, which is owned by Danaher, said the analyzer is a complement to its DxH 520 system.